IRIS
Di Lorenzo, Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 440
EU - Europa 110
NA - Nord America 98
OC - Oceania 3
SA - Sud America 2
Totale 653
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 328
HK - Hong Kong 96
IT - Italia 67
US - Stati Uniti d'America 46
MX - Messico 39
NL - Olanda 15
CA - Canada 13
DE - Germania 12
ID - Indonesia 11
UA - Ucraina 10
AU - Australia 3
ES - Italia 3
BR - Brasile 2
GB - Regno Unito 2
IN - India 2
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
JP - Giappone 1
RU - Federazione Russa 1
Totale 653
Salva come PNG Salva come JPEG
Città #
Singapore 155
Hong Kong 81
Mexico City 39
Rome 28
Naples 14
Chicago 7
Nepean 4
Milan 3
San Lorenzello 3
Vancouver 3
Abbotsford 2
Calvisano 2
Cesena 2
Domicella 2
Hamilton 2
Melbourne 2
Oxford 2
Palermo 2
Salt Lake City 2
Venice 2
Amsterdam 1
Ashburn 1
Clinton 1
Council Bluffs 1
Dhaka 1
Dubai 1
Elk Grove Village 1
Lancaster 1
Mesagne 1
Porto Alegre 1
Prineville 1
Rochester 1
Rostov-on-Don 1
Sedico 1
Sydney 1
São Luís 1
Tampa 1
Tokyo 1
Toronto 1
Totale 376
Salva come PNG Salva come JPEG
Nome #
Clinical trials enrollment disparities: Focus on male, transgender and gender diverse patients 27
Clinical characteristics of metastatic prostate cancer patients infected with COVID-19 in South Italy 15
Validation of Psychometric Tools for Assessing Fatigue, Mood, and Sleep Quality: Application in the PREVES-STOP Study. 15
Impact of Dietary Supplements on Clinical Outcomes and 2 Quality of Life in Patients with Breast Cancer: A Systematic Review 8
Paclitaxel in Pretreated Metastatic Penile Cancer: Final Results of a Phase 2 Study 7
Everolimus as second-line therapy for metastatic renal cell carcinoma: a 'real-life' study 7
Development and Validation of the PREVESMED Questionnaire: A Comprehensive Tool for Assessing Adherence to a Mediterranean Lifestyle 6
The Effect of Vaccination against COVID-19 in Cancer Patients: Final Results of the COICA Trial 6
A case of renal melanoma metastasis: Description of clinico-pathological features 6
A comprehensive outlook on intracerebral therapy of malignant gliomas. 6
Prostate Cancer Detection in the "Grey Area" of Prostate-Specific Antigen Below 10 ng/ml: Head-to-Head Comparison of the Updated PCPT Calculator and Chun's Nomogram, Two Risk Estimators Incorporating Prostate Cancer Antigen 3 5
Adverse Events of Immune Checkpoint Inhibitors Therapy for Urologic Cancer Patients in Clinical Trials: A Collaborative Systematic Review and Meta-analysis 5
Cardiovascular toxicity following sunitinib therapy in metastatic renal cell carcinoma: a multicenter analysis 5
Predictors of Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Urothelial Carcinoma: A Systematic Review and Meta-Analysis 5
Perioperative Immune Checkpoint Inhibitors in Renal Cell and Urothelial Carcinomas: An Exciting New Paradigm under Investigation? 5
Is gemcitabine an option in BCG-refractory nonmuscle-invasive bladder cancer? A single-arm prospective trial 5
Focus on localized laryngeal amyloidosis: Management of five cases 5
The Development and Initial Validation of the REST Questionnaire: A Multidimensional Tool for Assessing Fatigue in Individuals with and Without a History of Cancer 5
ADVERSE EVENTS 1 OF IMMUNE CHECKPOINT INHIBITORS THERAPYFOR UROLOGIC CANCER PATIENTS IN CLINICAL TRIALS: A COLLABORATIVE SYSTEMATIC REVIEW AND META ANALYSIS 5
Association of prior local therapy and outcomes with programmed-death ligand-1 inhibitors in advanced urothelial cancer 5
READY: Real-world data from an Italian compassionate use program of avelumab first-line maintenance (1LM) treatment for locally advanced or metastatic urothelial carcinoma (la/mUC) 5
Prospective evaluation of entrainment mapping as an adjunct to new-generation high-density activation mapping systems of left atrial tachycardias 5
Sipuleucel-T (Provenge®) for castration-resistant prostate cancer 5
Activity of platinum-based chemotherapy in advanced prostate cancer patients with and without DNA repair gene aberrations: An International Collaborative Analysis 5
Combination of Bevacizumab and Docetaxel in Docetaxel-Pretreated Hormone-Refractory Prostate Cancer: A Phase 2 Study 4
Phase II trial of gemcitabine, prednisone, and zoledronic acid in pretreated patients with hormone refractory prostate cancer 4
Metabolomic profiling for the identification of novel diagnostic markers and therapeutic targets in prostate cancer: an update 4
The use of tamsulosin in the medical treatment of ureteral calculi: Where do we stand? 4
Testicular cancer from diagnosis to epigenetic factors 4
Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor 4
Phase II trial of cisplatin plus prednisone in docetaxel-refractory castration-resistant prostate cancer patients 4
Coronavirus disease (COVID-19) in Italy: Analysis of risk factors and proposed remedial measures 4
Association Between Sites of Metastasis and Outcomes With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma 4
Nefrectomia citoriduttiva e palliativa 4
Combined magnetic resonance spectroscopy and dynamic contrast-enhanced imaging for prostate cancer detection 4
Authors' reply 4
A risk-group classification model in patients with bladder cancer under neoadjuvant cisplatin-based combination chemotherapy 4
The Impact of Flavonoid Supplementation on Serum Oxidative Stress Levels Measured via D-ROMs Test in the General Population: The PREVES-FLAVON Retrospective Observational Study 4
Soluble interleukin-6 receptor to interleukin-6 (sIL-6R/IL-6) ratio in serum as a predictor of high Gleason sum at radical prostatectomy 4
Concurrent Chemoradiotherapy for Men With Locally Advanced Penile Squamous Cell Carcinoma 4
Real-world experience with cabazitaxel in patients with metastatic castration-resistant prostate cancer: a final, pooled analysis of the compassionate use programme and early access programme 4
Castration-Resistant Prostate Cancer Current and Emerging Treatment Strategies 4
Incidence of fatigue and low dose of corticosteroids in patients receiving systemic treatment: a metanalysis of randomized trials 4
Docetaxel, vinorelbine, and zoledronic acid as first-line treatment in patients with hormone refractory prostate cancer: A phase II study 4
Re: Matthew R. Smith, Maha Hussain, Fred Saad, et al. Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer. N Engl J Med. 2022;386:1132–1142 4
A Challenging Surgical Approach to Locally Advanced Primary Urethral Carcinoma: A Case Report and Literature Review 4
The Impact of Routine Molecular Screening for SARS-CoV-2 in Patients Receiving Anticancer Therapy: An Interim Analysis of the Observational COICA Study 4
Association of prior local therapy and outcomes with PD(L)1 inhibitors in advanced urothelial cancer 4
Interaction between electromagnetic waves and auditory organs 4
Predicting prostate biopsy outcome: prostate health index (phi) and prostate cancer antigen 3 (PCA3) are useful biomarkers 4
Renal cell carcinoma guideline 4
Adrenal sparing surgery in the treatment of renal cell carcinoma: when is it possible? 4
Second line therapy with axitinib after only prior sunitinib in metastatic renal cell cancer: Italian multicenter real world SAX study final results 4
Fisetin as an adjuvant treatment in prostate cancer patients receiving androgen-deprivation therapy 4
BAG3 protein delocalisation in prostate carcinoma 4
Novel Chemotherapy-Sparing Approach for HER2-Low, ER-Positive Breast Cancer: Combining Trastuzumab Deruxtecan with Endocrine Therapy 4
KIDNEY CANCER Overall survival is an unsuitable primary end point 4
Re: Silke Gillessen Sommer, Thomas Powles. Advice for Medical Oncology Care of Urological Cancer Patients During the COVID-19 Pandemic. Eur Urol 2020;78:e2–3: Is It Always Correct to Continue Androgen Receptor Signaling Inhibitors in the COVID-19 Era? 4
Re: Impact of Relugolix Versus Leuprolide on the Quality of Life of Men with Advanced Prostate Cancer: Results from the Phase 3 HERO Study 4
Pegylated liposomal doxorubicin in stage IVB mycosis fungoides 4
Expression of HECA-452 antigen correlates with disease relapse in mycosis fungoides 4
The Role of Sipuleucel-T in Therapy for Castration-Resistant Prostate Cancer: A Critical Analysis of the Literature 4
Clinical outcomes in a contemporary series of "young" patients with castration-resistant prostate cancer who were 60 years and younger 4
Medical expulsive treatment of distal-ureteral stones using tamsulosin: A single-center experience 4
Supplements in Oncology: Uses, Hurdles, Guidance, and Future Perspective. 4
A Retrospective Study of Cemiplimab Effectiveness in Elderly Patients with Squamous Cell Carcinoma of the Skin: Insights from a Real-Life Scenario 4
Antagonistic effects of chloroquine on autophagy occurrence potentiate the anticancer effects of everolimus on renal cancer cells 4
Activity and safety of pegylated liposomal doxorubicin, 5-fluorouracil and folinic acid in inoperable hepatocellular carcinoma: A phase II study 3
Sunitinib administered on 2/1 schedule in patients with metastatic renal cell carcinoma: the RAINBOW analysis 3
Kaempferol, myricetin and fisetin in prostate and bladder cancer: A systematic review of the literature 3
TUMORI UROLOGICI: PROSTATA, RENE E VESCICA 3
Vesicourethral anastomosis during radical retropubic prostatectomy: Does the number of sutures matter? 3
Poor survival in prostate cancer patients with primary refractoriness to docetaxel 3
Intralabyrinthine Schwannoma of the Intravestibular Subtype: A Difficult Diagnosis 3
Thalidomide in combination with oral daily cyclophosphamide in patients with pretreated hormone refractory prostate cancer: A phase I clinical trial 3
Management of kidney cancer patients: 2018 guidelines of the Italian Medical Oncology Association 3
Sequential therapies in castration-resistant prostate cancer 3
Long lasting response to second-line everolimus in kidney cancer. 3
Immunotherapy for the treatment of prostate cancer 3
Predictors of efficacy of androgen-receptor-axis-targeted therapies in patients with metastatic castration-sensitive prostate cancer: a systematic review and meta-analysis 3
Adrenalectomy: defining its role in the surgical treatment of renal cell carcinoma. 3
TUMORI UROLOGICI: TUMORI DEL TESTICOLO, PROSTATA, RENE E VESCICA 3
Activity and safety of pegylated liposomal doxorubicin as first-line therapy in the treatment of non-visceral classic Kaposi's sarcoma: A multicenter study 3
Imatinib mesylate in thymic epithelial malignancies 3
Adjuvant treatment in patients at high risk of recurrence of thymoma: efficacy and safety of a three-dimensional conformal radiation therapy regimen 3
Unraveling the Dietary Puzzle: Exploring the Influence of Diet, Nutraceuticals, and Supplements on Bladder Cancer Risk, Outcomes, and Immunotherapy Efficacy: Insights from the BLOSSOM Study and Beyond 3
Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor 3
Gemcitabine Versus Bacille Calmette-Guerin After Initial Bacille Calmette-Guerin Failure in Non-Muscle-Invasive Bladder Cancer A Multicenter Prospective Randomized Trial 3
External beam radiotherapy in bone metastatic prostate cancer: impact on patients' pain relief and quality of life. 3
Matrix metalloproteinase-2 and-9 in the urine of prostate cancer patients 3
PHASE II STUDY OF PACLITAXEL IN PATIENTS WITH METASTATIC PENILE CANCER 3
Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) Significantly Improve Prostate Cancer Detection at Initial Biopsy in a Total PSA Range of 2-10 ng/ml 3
Techniques of iconographic documentation [Techniche di documentazione iconografica] 3
Are Extended biopsies really necessary to improve prostate cancer detection ? 3
Editorial Comment on: Prognostic and Predictive Factors in Patients with Androgen-Independent Prostate Cancer Treated with Docetaxel and Estramustine: A Single Institution Experience 3
Penile cancer: current therapy and future directions 3
Urotensin II receptor on preoperative biopsy is associated with upstaging and upgrading in prostate cancer 3
Toxicities of Targeted Therapy and Their Management in Kidney Cancer 3
Phase II Study of Sorafenib in Patients With Sunitinib-Refractory Metastatic Renal Cell Cancer 3
Liquid biopsy in bladder cancer: State of the art and future perspectives 3
Totale 444
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.438
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.438
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/20251.014 0 0 0 28 338 19 114 372 101 42 0 0
Totale 1.014